Gene · 2118
Papers2,714
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
201 to 220 of 2,714
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| [Clinical and morphological characteristics of Ewing's sarcoma and the algorithm for diagnosing undifferentiated round cell sarcomas]. | Arkh Patol | 2023 | 37814845 | PubTator, text mining | PubMed |
| The impact of poor metabolic health on aggressive breast cancer: adipose tissue and tumor metabolism. | Front Endocrinol (Lausanne) | 2023 | 37800138 | PubTator, text mining | PubMed |
| Gene partners of the EWSR1 fusion may represent molecularly distinct entities. | Transl Oncol | 2023 | 37797367 | PubTator, text mining | PubMed |
| Rewiring of mitochondrial metabolism in therapy-resistant cancers: permanent and plastic adaptations. | Front Cell Dev Biol | 2023 | 37779896 | PubTator, text mining | PubMed |
| Prognostic significance of TP53 and PIK3CA mutations analyzed by next-generation sequencing in breast cancer. | Medicine (Baltimore) | 2023 | 37747019 | PubTator, text mining | PubMed |
| Aminobisphosphonates reactivate the latent reservoir in people living with HIV-1. | Front Immunol | 2023 | 37744358 | PubTator, text mining | PubMed |
| Pooled genetic screens to identify vulnerabilities in TERT-promoter-mutant glioblastoma. | Oncogene | 2023 | 37741952 | PubTator, text mining | PubMed |
| Advancement of single-cell sequencing for clinical diagnosis and treatment of pancreatic cancer. | Front Med (Lausanne) | 2023 | 37720505 | PubTator, text mining | PubMed |
| Tendon tissue engineering: An overview of biologics to promote tendon healing and repair. | J Tissue Eng | 2023 | 37719308 | PubTator, text mining | PubMed |
| AIB1/SRC-3/NCOA3 function in estrogen receptor alpha positive breast cancer. | Front Endocrinol (Lausanne) | 2023 | 37711895 | PubTator, text mining | PubMed |
| Disorder-based T cell developmental order. | Nat Immunol | 2023 | 37709987 | PubTator, text mining | PubMed |
| Preferential FGF18/FGFR activity in pseudoglandular versus canalicular stage human lung fibroblasts. | Front Cell Dev Biol | 2023 | 37701781 | PubTator, text mining | PubMed |
| The functions and regulatory pathways of S100A8/A9 and its receptors in cancers. | Front Pharmacol | 2023 | 37701037 | PubTator, text mining | PubMed |
| Deciphering a shared transcriptomic regulation and the relative contribution of each regulator type through endometrial gene expression signatures. | Reprod Biol Endocrinol | 2023 | 37700285 | PubTator, text mining | PubMed |
| Integrative analysis of mitochondrial metabolic reprogramming in early-stage colon and liver cancer. | Front Oncol | 2023 | 37692839 | PubTator, text mining | PubMed |
| Lineage Plasticity and Stemness Phenotypes in Prostate Cancer: Harnessing the Power of Integrated "Omics" Approaches to Explore Measurable Metrics. | Cancers (Basel) | 2023 | 37686633 | PubTator, text mining | PubMed |
| Real-Time Evaluation of Thyroid Cytology Using New Digital Microscopy Allows for Sample Adequacy Assessment, Morphological Classification, and Supports Molecular Analysis. | Cancers (Basel) | 2023 | 37686491 | PubTator, text mining | PubMed |
| Poly(ADP-ribose) Polyremase-1 (PARP-1) Inhibition: A Promising Therapeutic Strategy for ETS-Expressing Tumours. | Int J Mol Sci | 2023 | 37686260 | PubTator, text mining | PubMed |
| The SGLT2 inhibitor canagliflozin suppresses growth and enhances prostate cancer response to radiotherapy. | Commun Biol | 2023 | 37684337 | PubTator, text mining | PubMed |
| Integrins and Actions of Androgen in Breast Cancer. | Cells | 2023 | 37681860 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/2118/papers?page=11